Reevaluation of the Systematic Review of the Traditional Chinese Medicine Combined with Transarterial Che-moembolization in the Treatment of Primary Liver Cancer

VernacularTitle:中药联合肝动脉化疗栓塞术治疗原发性肝癌系统评价的再评价Δ
Author: Lu GU ; Dongmei WU ; Ping XIE
Publication Type:Journal Article
Keywords: Transarterial chemoembolization; Primary liver cancer; Traditional Chinese medicine; Systematic review
From: China Pharmacy 2016;27(15):2073-2075,2076
CountryChina
Language:Chinese
Abstract: OBJECTIVE:To evaluate the methodological bias of systematic review and the reliability of counclusions of tradi-tional Chinese medicine (TCM) combined with transarterial chemoembolization in the treatment of primary liver cancer,and pro-vide evidence-based reference. METHODS:Retrieved from Cochrane Library,PubMed,Guideline,CBM,CJFD and Wanfang Da-tabase,high quality systematic review about TCM combined with transarterial chemoembolization in the treatment of primary liver cancer was collected for reevaluation. RESULTS:Totally 12 systematic review were involved. Results showed TCM combined with transarterial chemoembolization can improve tumor’s objective response,prolong the survival time of patients,improve life quali-ty,reduce postoperative adverse reactions with no serious adverse reactions reported related to TCM in the treatment of primary liv-er cancer. CONCLUSIONS:The clinical efficacy of TCM combined with transarterial chemoembolization is superior to transarterial chemoembolization alone in the treatment of primary liver cancer,with better safety.